We thank the editors for the opportunity to respond to the commentary written by Li et al., 2022, in response to our recent publication [1]. We also thank Li et al. for their interest in our work and would like to note their additional commentary.
The commentary raises questions: Were any differences found between the hypertensive
disorder of pregnancy patients with and without proteinuria? Another limitation is
that there were no non-pregnant women as controls. What are the background urine metabolite signatures
in women? Are there any differences between the two groups? How are they changed when
pregnancy occurs? Do they have the same change patterns for the two groups? We have
addressed them below:
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to American Journal of Obstetrics & Gynecology MFMAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Article info
Publication history
Accepted:
January 10,
2023
Received:
December 30,
2022
Reply to the letter to the editor:Publication stage
In Press Accepted ManuscriptFootnotes
Conflict of interest: The authors report no conflict of interest.
Identification
Copyright
© 2023 Elsevier Inc. All rights reserved.
